Request for Covid-19 Impact Assessment of this Report
Sales, means the sales volume of Axitinib
Revenue, means the sales value of Axitinib
This report studies sales (consumption) of Axitinib in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Pfizer
Allergan
Alnylam Pharmaceuticals
Amgen
Angstrom Pharmaceuticals
Acceleron Pharma
Biocon
Bionomics
CASI Pharmaceuticals
Celgene Corporation
Enzon Pharmaceuticals
Five Prime Therapeutics
Fujifilm Kyowa Kirin Biologics
Genentech
Genexine
Hetero Drugs
ImClone Systems
Intas Pharmaceuticals
Kyowa Hakko Kirin
Levolta Pharmaceuticals
Mabtech
Marsala Biotech
Neumedicines
Novartis
Oncobiologics
Onyx Pharmaceuticals
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by applications, this report focuses on sales, market share and growth rate of Axitinib in each application, can be divided into
Application 1
Application 2
Application 3
United States Axitinib Market Report 2016
1 Axitinib Overview
1.1 Product Overview and Scope of Axitinib
1.2 Classification of Axitinib
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Axitinib
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 USA Market Size Sales (Value) and Revenue (Volume) of Axitinib (2011-2021)
1.4.1 USA Axitinib Sales and Growth Rate (2011-2021)
1.4.2 USA Axitinib Revenue and Growth Rate (2011-2021)
2 USA Axitinib Competition by Manufacturers
2.1 USA Axitinib Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Axitinib Revenue and Share by Manufactures (2015 and 2016)
2.3 USA Axitinib Average Price by Manufactures (2015 and 2016)
2.4 Axitinib Market Competitive Situation and Trends
2.4.1 Axitinib Market Concentration Rate
2.4.2 Axitinib Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 USA Axitinib Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 USA Axitinib Sales and Market Share by Type (2011-2016)
3.2 USA Axitinib Revenue and Market Share by Type (2011-2016)
3.3 USA Axitinib Price by Type (2011-2016)
3.4 USA Axitinib Sales Growth Rate by Type (2011-2016)
4 USA Axitinib Sales (Volume) by Application (2011-2016)
4.1 USA Axitinib Sales and Market Share by Application (2011-2016)
4.2 USA Axitinib Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 USA Axitinib Manufacturers Profiles/Analysis
5.1 Pfizer
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Axitinib Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Pfizer Axitinib Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Allergan
5.2.2 Axitinib Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Allergan Axitinib Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Alnylam Pharmaceuticals
5.3.2 Axitinib Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Alnylam Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Amgen
5.4.2 Axitinib Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Amgen Axitinib Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Angstrom Pharmaceuticals
5.5.2 Axitinib Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Angstrom Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Acceleron Pharma
5.6.2 Axitinib Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Acceleron Pharma Axitinib Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Biocon
5.7.2 Axitinib Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Biocon Axitinib Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Bionomics
5.8.2 Axitinib Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Bionomics Axitinib Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 CASI Pharmaceuticals
5.9.2 Axitinib Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 CASI Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Celgene Corporation
5.10.2 Axitinib Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Celgene Corporation Axitinib Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Enzon Pharmaceuticals
5.12 Five Prime Therapeutics
5.13 Fujifilm Kyowa Kirin Biologics
5.14 Genentech
5.15 Genexine
5.16 Hetero Drugs
5.17 ImClone Systems
5.18 Intas Pharmaceuticals
5.19 Kyowa Hakko Kirin
5.20 Levolta Pharmaceuticals
5.21 Mabtech
5.22 Marsala Biotech
5.23 Neumedicines
5.24 Novartis
5.25 Oncobiologics
5.26 Onyx Pharmaceuticals
6 Axitinib Manufacturing Cost Analysis
6.1 Axitinib Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Axitinib
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Axitinib Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Axitinib Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 USA Axitinib Market Forecast (2016-2021)
10.1 USA Axitinib Sales, Revenue Forecast (2016-2021)
10.2 USA Axitinib Sales Forecast by Type (2016-2021)
10.3 USA Axitinib Sales Forecast by Application (2016-2021)
10.4 Axitinib Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
Figure Picture of Axitinib
Table Classification of Axitinib
Figure USA Sales Market Share of Axitinib by Type in 2015
Table Application of Axitinib
Figure USA Sales Market Share of Axitinib by Application in 2015
Figure USA Axitinib Sales and Growth Rate (2011-2021)
Figure USA Axitinib Revenue and Growth Rate (2011-2021)
Table USA Axitinib Sales of Key Manufacturers (2015 and 2016)
Table USA Axitinib Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Axitinib Sales Share by Manufacturers
Figure 2016 Axitinib Sales Share by Manufacturers
Table USA Axitinib Revenue by Manufacturers (2015 and 2016)
Table USA Axitinib Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Axitinib Revenue Share by Manufacturers
Table 2016 USA Axitinib Revenue Share by Manufacturers
Table USA Market Axitinib Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market Axitinib Average Price of Key Manufacturers in 2015
Figure Axitinib Market Share of Top 3 Manufacturers
Figure Axitinib Market Share of Top 5 Manufacturers
Table USA Axitinib Sales by Type (2011-2016)
Table USA Axitinib Sales Share by Type (2011-2016)
Figure USA Axitinib Sales Market Share by Type in 2015
Table USA Axitinib Revenue and Market Share by Type (2011-2016)
Table USA Axitinib Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Axitinib by Type (2011-2016)
Table USA Axitinib Price by Type (2011-2016)
Figure USA Axitinib Sales Growth Rate by Type (2011-2016)
Table USA Axitinib Sales by Application (2011-2016)
Table USA Axitinib Sales Market Share by Application (2011-2016)
Figure USA Axitinib Sales Market Share by Application in 2015
Table USA Axitinib Sales Growth Rate by Application (2011-2016)
Figure USA Axitinib Sales Growth Rate by Application (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Axitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Axitinib Sales Market Share (2011-2016)
Table Allergan Basic Information List
Table Allergan Axitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Allergan Axitinib Sales Market Share (2011-2016)
Table Alnylam Pharmaceuticals Basic Information List
Table Alnylam Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Alnylam Pharmaceuticals Axitinib Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Axitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Axitinib Sales Market Share (2011-2016)
Table Angstrom Pharmaceuticals Basic Information List
Table Angstrom Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Angstrom Pharmaceuticals Axitinib Sales Market Share (2011-2016)
Table Acceleron Pharma Basic Information List
Table Acceleron Pharma Axitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Acceleron Pharma Axitinib Sales Market Share (2011-2016)
Table Biocon Basic Information List
Table Biocon Axitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biocon Axitinib Sales Market Share (2011-2016)
Table Bionomics Basic Information List
Table Bionomics Axitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bionomics Axitinib Sales Market Share (2011-2016)
Table CASI Pharmaceuticals Basic Information List
Table CASI Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Table CASI Pharmaceuticals Axitinib Sales Market Share (2011-2016)
Table Celgene Corporation Basic Information List
Table Celgene Corporation Axitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Celgene Corporation Axitinib Sales Market Share (2011-2016)
Table Enzon Pharmaceuticals Basic Information List
Table Enzon Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Enzon Pharmaceuticals Axitinib Sales Market Share (2011-2016)
Table Five Prime Therapeutics Basic Information List
Table Five Prime Therapeutics Axitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Five Prime Therapeutics Axitinib Sales Market Share (2011-2016)
Table Fujifilm Kyowa Kirin Biologics Basic Information List
Table Fujifilm Kyowa Kirin Biologics Axitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Fujifilm Kyowa Kirin Biologics Axitinib Sales Market Share (2011-2016)
Table Genentech Basic Information List
Table Genentech Axitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genentech Axitinib Sales Market Share (2011-2016)
Table Genexine Basic Information List
Table Genexine Axitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genexine Axitinib Sales Market Share (2011-2016)
Table Hetero Drugs Basic Information List
Table Hetero Drugs Axitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hetero Drugs Axitinib Sales Market Share (2011-2016)
Table ImClone Systems Basic Information List
Table ImClone Systems Axitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Table ImClone Systems Axitinib Sales Market Share (2011-2016)
Table Intas Pharmaceuticals Basic Information List
Table Intas Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Intas Pharmaceuticals Axitinib Sales Market Share (2011-2016)
Table Kyowa Hakko Kirin Basic Information List
Table Kyowa Hakko Kirin Axitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kyowa Hakko Kirin Axitinib Sales Market Share (2011-2016)
Table Levolta Pharmaceuticals Basic Information List
Table Levolta Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Levolta Pharmaceuticals Axitinib Sales Market Share (2011-2016)
Table Mabtech Basic Information List
Table Mabtech Axitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mabtech Axitinib Sales Market Share (2011-2016)
Table Marsala Biotech Basic Information List
Table Marsala Biotech Axitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Marsala Biotech Axitinib Sales Market Share (2011-2016)
Table Neumedicines Basic Information List
Table Neumedicines Axitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Neumedicines Axitinib Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Axitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Axitinib Sales Market Share (2011-2016)
Table Oncobiologics Basic Information List
Table Oncobiologics Axitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Oncobiologics Axitinib Sales Market Share (2011-2016)
Table Onyx Pharmaceuticals Basic Information List
Table Onyx Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Onyx Pharmaceuticals Axitinib Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Axitinib
Figure Manufacturing Process Analysis of Axitinib
Figure Axitinib Industrial Chain Analysis
Table Raw Materials Sources of Axitinib Major Manufacturers in 2015
Table Major Buyers of Axitinib
Table Distributors/Traders List
Figure USA Axitinib Production and Growth Rate Forecast (2016-2021)
Figure USA Axitinib Revenue and Growth Rate Forecast (2016-2021)
Table USA Axitinib Production Forecast by Type (2016-2021)
Table USA Axitinib Consumption Forecast by Application (2016-2021)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...